Vangipuram Malini, Ting Dennis, Kim Sam, Diaz Robert, Schüle Birgitt
Basic Research Department, The Parkinson's Institute.
J Vis Exp. 2013 Jul 7(77):e3779. doi: 10.3791/3779.
Tissues and cell lines derived from an individual with disease are ideal sources to study disease-related cellular phenotypes. Patient-derived fibroblasts in this protocol have been successfully used in the derivation of induced pluripotent stem cells to model disease(1). Early passages of these fibroblasts can also be used for cell-based functional assays to study specific disease pathways, mechanisms(2) and subsequent drug screening approaches. The advantage of the presented protocol over enzymatic procedures are 1) the reproducibility of the technique from small amounts of tissue derived from older patients, e.g. patients affected with Parkinson's disease, 2) the technically simple approach over more challenging methodologies using enzymatic treatments, and 3) the time consideration: this protocol takes 15-20 min and can be performed immediately after biopsy arrival. Enzymatic treatments can take up to 4 hr and have the problems of overdigestion, reduction of cell viability and subsequent attachment of cells when not handled properly. This protocol describes the dissection and preparation of a 4-mm human skin biopsy for derivation of a fibroblast culture and has a very high success rate which is important when dealing with patient-derived tissue samples. In this culture, keratinocytes migrate out of the biopsy tissue within the first week after preparation. Fibroblasts appear 7-10 days after the first outgrowth of keratinocytes. DMEM high glucose media supplemented with 20% FBS favors the growth of fibroblasts over keratinocytes and fibroblasts will overgrow the keratinocytes. After 2 passages keratinocytes have been diluted out resulting in relatively homogenous fibroblast cultures which expresses the fibroblast marker SERPINH1 (HSP-47). Using this approach, 15-20 million fibroblasts can be derived in 4-8 weeks for cell banking. The skin dissection takes about 15-20 min, cells are then monitored once a day under the microscope, and media is changed every 2-3 days after attachment and outgrowth of cells.
源自患有疾病个体的组织和细胞系是研究疾病相关细胞表型的理想来源。本方案中患者来源的成纤维细胞已成功用于诱导多能干细胞的诱导,以模拟疾病(1)。这些成纤维细胞的早期传代也可用于基于细胞的功能测定,以研究特定疾病途径、机制(2)及后续药物筛选方法。本方案相对于酶促方法的优势在于:1)该技术可从老年患者(如帕金森病患者)的少量组织中重复获得;2)与使用酶处理的更具挑战性的方法相比,该方法技术简单;3)时间方面:本方案耗时15 - 20分钟,活检组织送达后即可立即进行。酶促处理可能需要长达4小时,且存在消化过度、细胞活力降低以及处理不当会导致细胞后续贴壁等问题。本方案描述了用于成纤维细胞培养的4毫米人皮肤活检组织的解剖和制备过程,成功率非常高,这在处理患者来源的组织样本时很重要。在这种培养中,角质形成细胞在制备后的第一周内从活检组织中迁移出来。成纤维细胞在角质形成细胞首次生长7 - 10天后出现。添加20%胎牛血清的高糖DMEM培养基有利于成纤维细胞而非角质形成细胞的生长,成纤维细胞会超过角质形成细胞生长。经过2次传代后,角质形成细胞被稀释掉,从而得到相对均匀的成纤维细胞培养物,其表达成纤维细胞标志物SERPINH1(热休克蛋白47)。采用这种方法,4 - 8周内可获得1500 - 2000万个成纤维细胞用于细胞冻存。皮肤解剖大约需要15 - 20分钟,然后每天在显微镜下监测细胞,细胞贴壁并生长后每2 - 3天更换一次培养基。